Log in or Sign up for Free to view tailored content for your specialty!
Stroke News
IV thrombolysis may be safe in patients with ischemic stroke aged 90 years or older
The odds of 3-month symptomatic intracranial hemorrhage following IV thrombolysis for ischemic stroke among patients aged 90 years or older were not greater compared with younger patients, researchers reported.
COVID-19 confers risk for death, CV events, especially in hospitalized patients
Compared with uninfected controls, patients hospitalized for COVID-19 had elevated risk for death and CV events, according to new data from the UK Biobank.
Log in or Sign up for Free to view tailored content for your specialty!
AXIOMATIC-SSP
Addition of an oral factor XIa inhibitor to aspirin and clopidogrel vs. standard therapy for stroke prevention.
Higher BMI tied to early AF risk in young men
Increasing BMI in young adult men is strongly associated with early atrial fibrillation as well as later worse clinical outcomes, including incident HF, stroke and all-cause mortality, among those diagnosed with AF, researchers reported.
Patients with intracerebral hemorrhage at greater risk for cardiovascular events
Patients with stroke due to nontraumatic intracerebral hemorrhage had significantly higher rates of major adverse cardiovascular events, researchers reported in JAMA Network Open.
Greater total dairy, milk intake related to higher risk for stroke, mortality in angina
In patients with stable angina, increased risk for stroke and mortality was positively correlated with higher consumption of milk and total dairy intake, researchers reported in the European Journal of Preventive Cardiology.
Gestational diabetes increases risks for CV, cerebrovascular diseases
Women with gestational diabetes have increased risks for overall and specific types of cardiovascular and cerebrovascular diseases, whether or not they go on to develop type 2 diabetes, according to study data published in The BMJ.
Major cardiac events not more common in patients receiving JAK inhibitors vs adalimumab
The risks for major adverse cardiac events and venous thromboembolism in patients with rheumatoid arthritis did not significantly differ between those receiving Janus kinase inhibitors or adalimumab, according to data.
The Take Home: ESC Congress
The European Society of Cardiology Congress was held Aug. 26 to 29 in Barcelona, Spain, and online, having an in-person component for the first time since 2019.
AHA announces late-breaking science lineup to be presented at 2022 Scientific Sessions
The American Heart Association Scientific Sessions will be held live in Chicago and can be attended virtually Nov. 5 to 7, and will feature nine late-breaking science sessions over 3 days.
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read